PharmRep Direct from the editors of Pharmaceutical Representative Visit www.PharmRep.com Today!

September 17th, 2009 Issue 37 Vol. 10
www.pharmrep.com  
Contact Editor: Reid Paul
PharmRep Direct News

Lilly Shuffles Staff, Cuts Thousands of Jobs
Eli Lilly is following the lead of Pfizer and J&J by restructuring its pharma division into separate business units with new leaders running each segment. The bad news is that 5,500 jobs will be left on the cutting room floor as part of the plan.
» MORE

J&J Slims Down Elan Offer sans Tysabri
Elan was forced to trim $100 million off its billion-dollar deal with J&J due to a 50/50 agreement with Biogen Idec involving co-ownership of MS drug Tysabri. Now J&J is out a major drug, Elan is out a good chunk of cash, and Biogen Idec is pondering its next move.
» MORE

It's Time to Slow Down the Pace of Medical Treatment
More doctors are turning their back on private insurers to reduce overhead and open up more time to spend with patients
» MORE

Parents Weigh Options for H1N1 Vaccination
It’s not just concerns over autism that concern some parents who worry about whether vaccinating is the right solution
» MORE

PharmRep Direct Features

The Skinny on Weight Loss Drugs
The obesity pipeline, despite a hugely underserved market potentially worth $11 billion, is awfully thin
» MORE

Adherence to Cardiovascular Medications in the Elderly
Elderly patients pose particular problems for doctors trying to address problems with adherence to medication.
» MORE

Psoriasis Linked to Metabolic Syndrome

The evidence linking psoriasis to metabolic syndrome and cardiovascular disease is overwhelming, classifying psoriasis as a systemic disease and not simply a disease of the skin
» MORE


 
FindPharma   Search
 
Subscribe To PharmRep Today!
PharmRep Direct Survey, Vote Today!
The more people talk about healthcare reform the less consensus there is, what do you think of current efforts to reform the system?
Click Here to Vote

PharmRep Direct Quick Links
Costs To Rise, Benefits Shrink In 2010

Breast Cancer Drugs Bear Health Cautions

The Biggest Long-Term Health Challenge



Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit PharmRep.com Today! Visit www.PharmRep.com Today!